Literature DB >> 33170143

Surgical resection of synchronous liver metastases in gastric cancer patients. A propensity score-matched study.

Tomaz Jagric1, Matjaz Horvat2.   

Abstract

Background The aim of the study was to determine the value of synchronous liver resection in patients with oligo-metastatic gastric cancer and the prognostic factors in these patients. Patients and methods We compared the results of 21 gastric patients with liver metastases and synchronous liver resection (LMR) to 21 propensity score-matched patients with gastric cancer and liver metastases in whom liver resection was not performed (LM0) and to a propensity score-matched control group of 21 patients without liver metastases and stage III and IV resectable gastric cancer (CG). Results The overall 5-year survival of LMR, LM0 and CG were 14.3%, 0%, and 19%, respectively (p = 0.002). Five-year survival was 47.5% for well-differentiated tumour compared to 0% in patients with moderate or poor tumour differentiation (p = 0.006). In addition, patients with R0 resection and TNM stage N0-1 had a significantly better survival compared to patients with TNM N stage N2-3 (5-year survival: 60% for N0-1 vs. 7.7% for N2-3; p = 0.007). Conclusions The results presented in the study support synchronous liver resections in gastric patients and provide additional criteria for patient selection.

Keywords:  gastric cancer; liver metastases; propensity score; synchronous resection

Year:  2020        PMID: 33170143     DOI: 10.2478/raon-2020-0067

Source DB:  PubMed          Journal:  Radiol Oncol        ISSN: 1318-2099            Impact factor:   2.991


  19 in total

1.  Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial.

Authors:  Yung-Jue Bang; Eric Van Cutsem; Andrea Feyereislova; Hyun C Chung; Lin Shen; Akira Sawaki; Florian Lordick; Atsushi Ohtsu; Yasushi Omuro; Taroh Satoh; Giuseppe Aprile; Evgeny Kulikov; Julie Hill; Michaela Lehle; Josef Rüschoff; Yoon-Koo Kang
Journal:  Lancet       Date:  2010-08-19       Impact factor: 79.321

2.  Nomenclature of hepatic anatomy and resections: a review of the Brisbane 2000 system.

Authors:  Steven M Strasberg
Journal:  J Hepatobiliary Pancreat Surg       Date:  2005

3.  The prognosis role of AJCC/UICC 8th edition staging system in gastric cancer, a retrospective analysis.

Authors:  Jiu-Yang Liu; Chun-Wei Peng; Xiao-Jun Yang; Chao-Qun Huang; Yan Li
Journal:  Am J Transl Res       Date:  2018-01-15       Impact factor: 4.060

4.  Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomised controlled surgical trial. The Surgical Cooperative Group.

Authors:  A Cuschieri; P Fayers; J Fielding; J Craven; J Bancewicz; V Joypaul; P Cook
Journal:  Lancet       Date:  1996-04-13       Impact factor: 79.321

5.  Long-term outcomes after surgical resection for gastric cancer liver metastasis: an analysis of 64 macroscopically complete resections.

Authors:  Nobuyuki Takemura; Akio Saiura; Rintaro Koga; Junichi Arita; Ryuji Yoshioka; Yoshihiro Ono; Naoki Hiki; Takeshi Sano; Junji Yamamoto; Norihiro Kokudo; Toshiharu Yamaguchi
Journal:  Langenbecks Arch Surg       Date:  2012-05-22       Impact factor: 3.445

6.  Multicentre analysis of long-term outcome after surgical resection for gastric cancer liver metastases.

Authors:  T Kinoshita; T Kinoshita; A Saiura; M Esaki; H Sakamoto; T Yamanaka
Journal:  Br J Surg       Date:  2014-11-12       Impact factor: 6.939

7.  Surgical treatment of liver metastasis of gastric cancer: a retrospective multicenter cohort study (KSCC1302).

Authors:  Eiji Oki; Shoji Tokunaga; Yasunori Emi; Tetsuya Kusumoto; Manabu Yamamoto; Kengo Fukuzawa; Ikuo Takahashi; Sumiya Ishigami; Akihito Tsuji; Hidefumi Higashi; Toshihiko Nakamura; Hiroshi Saeki; Ken Shirabe; Yoshihiro Kakeji; Kenji Sakai; Hideo Baba; Tadashi Nishimaki; Shoji Natsugoe; Yoshihiko Maehara
Journal:  Gastric Cancer       Date:  2015-08-11       Impact factor: 7.370

8.  Analysis of hepatic resection of metastasis originating from gastric adenocarcinoma.

Authors:  Johannes Zacherl; Maximilian Zacherl; Christian Scheuba; Rudolf Steininger; Etienne Wenzl; Ferdinand Mühlbacher; Raimund Jakesz; Friedrich Längle
Journal:  J Gastrointest Surg       Date:  2002 Sep-Oct       Impact factor: 3.452

9.  Gastrectomy plus chemotherapy versus chemotherapy alone for advanced gastric cancer with a single non-curable factor (REGATTA): a phase 3, randomised controlled trial.

Authors:  Kazumasa Fujitani; Han-Kwang Yang; Junki Mizusawa; Young-Woo Kim; Masanori Terashima; Sang-Uk Han; Yoshiaki Iwasaki; Woo Jin Hyung; Akinori Takagane; Do Joong Park; Takaki Yoshikawa; Seokyung Hahn; Kenichi Nakamura; Cho Hyun Park; Yukinori Kurokawa; Yung-Jue Bang; Byung Joo Park; Mitsuru Sasako; Toshimasa Tsujinaka
Journal:  Lancet Oncol       Date:  2016-01-26       Impact factor: 41.316

10.  Stage IV Gastric Cancer: The Surgical Perspective of the Italian Research Group on Gastric Cancer.

Authors:  Silvia Ministrini; Maria Bencivenga; Leonardo Solaini; Chiara Cipollari; Silvia Sofia; Elisabetta Marino; Alessia d'Ignazio; Beatrice Molteni; Gianni Mura; Daniele Marrelli; Maurizio Degiuli; Annibale Donini; Franco Roviello; Giovanni de Manzoni; Paolo Morgagni; Guido A M Tiberio
Journal:  Cancers (Basel)       Date:  2020-01-09       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.